Filed: 8/9/2024ACC: 0001104659-24-087431
π What this filing means
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC filed this quarterly 13FβHR report disclosing 15 equity positions with a total reported market value of $949.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$949.64M
Total AUM (reported)
60.53M
Total Shares
Allocation by class
COMMON STOCK$949.64M100.0%
Portfolio Concentration
Top 3$584.54M61.6%
4β10$343.36M36.2%
11β25$21.74M2.3%
Top 3 weight
61.6%
Top 10 weight
97.7%
Voting Authority Distribution
Total shares with voting rights: 60.53M
Sole
Full voting authority
60.53M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings15
Rows:
Dyne Therapeutics, Inc.
SOLEShares8.02M
TypeSH
Market value$283.03M
29.80%
Sole
8.02M
Shared
0.00
None
0.00
Kymera Therapeutics, Inc.
SOLEShares5.35M
TypeSH
Market value$159.71M
16.82%
Sole
5.35M
Shared
0.00
None
0.00
Third Harmonic Bio, Inc.
SOLEShares10.91M
TypeSH
Market value$141.80M
14.93%
Sole
10.91M
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares2.51M
TypeSH
Market value$113.10M
11.91%
Sole
2.51M
Shared
0.00
None
0.00
Day One Biopharmaceuticals, Inc.
SOLEShares6.43M
TypeSH
Market value$88.61M
9.33%
Sole
6.43M
Shared
0.00
None
0.00
Korro Bio, Inc.
SOLEShares1.14M
TypeSH
Market value$38.52M
4.06%
Sole
1.14M
Shared
0.00
None
0.00
Q32 Bio, Inc.
SOLEShares2.09M
TypeSH
Market value$37.55M
3.95%
Sole
2.09M
Shared
0.00
None
0.00
Generation Bio, Co.
SOLEShares8.28M
TypeSH
Market value$23.35M
2.46%
Sole
8.28M
Shared
0.00
None
0.00
Vigil Neuroscience, Inc.
SOLEShares5.84M
TypeSH
Market value$23.35M
2.46%
Sole
5.84M
Shared
0.00
None
0.00
Replimune Group, Inc.
SOLEShares2.10M
TypeSH
Market value$18.88M
1.99%
Sole
2.10M
Shared
0.00
None
0.00
Ikena Oncology, Inc.
SOLEShares5.02M
TypeSH
Market value$8.28M
0.87%
Sole
5.02M
Shared
0.00
None
0.00
Tectonic Therapeutics, Inc.
SOLEShares378.45K
TypeSH
Market value$6.23M
0.66%
Sole
378.45K
Shared
0.00
None
0.00
Dianthus Therapeutics, Inc.
SOLEShares136.98K
TypeSH
Market value$3.55M
0.37%
Sole
136.98K
Shared
0.00
None
0.00
Aerovate Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$2.99M
0.31%
Sole
1.80M
Shared
0.00
None
0.00
Spero Therapeutics, Inc.
SOLEShares535.34K
TypeSH
Market value$695.9K
0.07%
Sole
535.34K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc.SOLE | Common Stock | 8.02M | SH | $283.03M 29.80% | 8.02M | 0.00 | 0.00 |
Kymera Therapeutics, Inc.SOLE | Common Stock | 5.35M | SH | $159.71M 16.82% | 5.35M | 0.00 | 0.00 |
Third Harmonic Bio, Inc.SOLE | Common Stock | 10.91M | SH | $141.80M 14.93% | 10.91M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | Common Stock | 2.51M | SH | $113.10M 11.91% | 2.51M | 0.00 | 0.00 |
Day One Biopharmaceuticals, Inc.SOLE | Common Stock | 6.43M | SH | $88.61M 9.33% | 6.43M | 0.00 | 0.00 |
Korro Bio, Inc.SOLE | Common Stock | 1.14M | SH | $38.52M 4.06% | 1.14M | 0.00 | 0.00 |
Q32 Bio, Inc.SOLE | Common Stock | 2.09M | SH | $37.55M 3.95% | 2.09M | 0.00 | 0.00 |
Generation Bio, Co.SOLE | Common Stock | 8.28M | SH | $23.35M 2.46% | 8.28M | 0.00 | 0.00 |
Vigil Neuroscience, Inc.SOLE | Common Stock | 5.84M | SH | $23.35M 2.46% | 5.84M | 0.00 | 0.00 |
Replimune Group, Inc.SOLE | Common Stock | 2.10M | SH | $18.88M 1.99% | 2.10M | 0.00 | 0.00 |
Ikena Oncology, Inc.SOLE | Common Stock | 5.02M | SH | $8.28M 0.87% | 5.02M | 0.00 | 0.00 |
Tectonic Therapeutics, Inc.SOLE | Common Stock | 378.45K | SH | $6.23M 0.66% | 378.45K | 0.00 | 0.00 |
Dianthus Therapeutics, Inc.SOLE | Common Stock | 136.98K | SH | $3.55M 0.37% | 136.98K | 0.00 | 0.00 |
Aerovate Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $2.99M 0.31% | 1.80M | 0.00 | 0.00 |
Spero Therapeutics, Inc.SOLE | Common Stock | 535.34K | SH | $695.9K 0.07% | 535.34K | 0.00 | 0.00 |